Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Could Pfizer Be Dragged Into EU’s Vaccine Dispute With AstraZeneca and UK?

Reprisals Against UK Not Ruled Out

Executive Summary

The European Commission is once again threatening to block exports of COVID-19 vaccines to the UK – including those from Pfizer/BioNTech.

You may also be interested in...



Coronavirus Notebook: UK Tests Preventative Treatments As Row Escalates With EU Over Vaccine Supply

The procurement and authorization of vaccines are under scrutiny in the European Parliament this week. In the meantime, another Sputnik V spat is taking wing between Russia and the EU, while France has resumed the use of AstraZeneca’s vaccine, but only in the over-55s.

Europe To Resume AZ Vaccine Use After Safety Review, But Confidence Knocked

The EMA’s conclusions are in line with those of the UK regulator and the World Health Organization, but EU countries’ stop-start decisions will have done nothing to boost the public’s trust in the vaccine.

Vaccitech Prepares For IPO, But AZ COVID-19 Vaccine Safety Fears Cloud Launch

The UK biotech aims to raise $100m, but will need to tackle safety concerns to secure a long-term future.

Topics

Related Companies

UsernamePublicRestriction

Register

SC144033

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel